文献速递细菌感染、耐药与抗菌药物

骨活检与深部组织培养在糖尿病足骨髓炎抗生素管理中的作用

Role of bone biopsy and deep tissue culture for antibiotic stewardship in diabetic foot osteomyelitis.
PubMed 文献 · J Antimicrob Chemother · 2022-01-01

该回顾性研究纳入2018年3月3日至2019年12月31日因糖尿病足溃疡入院并临床诊断下肢感染性骨髓炎的患者,比较获取骨活检或深部组织培养与否的抗生素使用率。共152例糖尿病足骨髓炎患者中,47例获取了41份深部组织培养和29份骨活检培养,培养数据使41例(87%)患者调整了抗生素方案。出院时抗生素使用率在获取与未获取培养组间无显著差异(77%对75%,P=0.86),但MRSA覆盖较少(34%对50%,P=0.047)。

要点

  • 糖尿病足骨髓炎患者中骨活检和深部组织培养不常进行,但培养数据使多数患者抗生素方案更具针对性。
  • 培养数据通常允许窄化抗生素,但在部分患者中显示经验性覆盖不足。
  • 获取培养与未获取培养的患者出院时抗生素使用率无显著差异,但MRSA覆盖较少。

核心结论

  • 在糖尿病足骨髓炎患者中,深部组织和骨活检培养不常获取,但使多数患者实现了针对性治疗调整;培养数据通常允许窄化抗生素,但在部分患者中显示经验性覆盖不足。

研究设计与样本

  • 回顾性研究,纳入2018年3月3日至2019年12月31日因糖尿病足溃疡入院并临床诊断下肢感染性骨髓炎的患者,按是否获取骨活检或深部组织培养进行分层,采用卡方检验和Fisher精确检验比较抗生素使用率。
  • 305例糖尿病足溃疡患者中152例(50%)临床诊断为糖尿病足骨髓炎。
  • 47例患者共获取41份深部组织培养和29份骨活检培养,合计70份培养。

主要发现

  • 45份(64%)培养阳性,其中36份(80%)检出革兰阳性菌,19份(42%)检出革兰阴性菌。
  • 7例(15%)患者分离出多重耐药菌。
  • 培养数据使41例(87%)患者调整了抗生素方案,其中29例(62%)窄化治疗,4例(9%)因经验性覆盖不足而拓宽治疗。
  • 18例(40%)患者的培养数据显示对高生物利用度口服治疗方案敏感。
  • 获取骨活检或深部组织培养的患者与未获取者相比,出院时抗生素使用率无显著差异(77%对75%,P=0.86),但MRSA覆盖较少(34%对50%,P=0.047)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe organisms most frequently identified on bone biopsy or deep tissue culture and determine how culture data impacted antibiotic management in patients with diabetic foot osteomyelitis (DFO). METHODS: We retrospectively reviewed patients admitted with a diabetic foot ulcer (DFU) between 3 March 2018 and 31 December 2019 and selected for patients diagnosed with infectious osteomyelitis (OM) of the lower extremity. We stratified patients by whether a bone biopsy or deep tissue culture was obtained and compared rates of antibiotic utilization with chi-squared and Fisher's exact tests. RESULTS: Of 305 patients with a DFU, 152 (50%) were clinically diagnosed with DFO. Forty-seven patients received 41 deep tissue cultures and 29 bone biopsy cultures for a total of 70 cultures. Of 45 (64%) positive cultures, 36 (80%) had Gram-positive organisms and 19 (42%) had Gram-negative organisms. MDR organisms were isolated in 7 (15%) patients. Culture data resulted in antibiotic changes in 41 (87%) patients. Therapy was narrowed in 29 (62%) patients and broadened due to inadequate empirical coverage in 4 (9%) patients. Culture data from 18 (40%) patients showed susceptibility to an oral treatment regimen with high bioavailability. There was no significant difference in rates of antibiotic utilization at discharge between patients who underwent bone biopsy or deep tissue culture relative to those who did not (77% versus 75%, P = 0.86), although less MRSA coverage was used (34% versus 50%, P = 0.047). CONCLUSIONS: In patients with DFO, deep tissue and bone biopsy cultures were infrequently obtained but resulted in targeted therapy changes in most patients. Culture data usually allowed for narrowing of antibiotics but revealed inadequate empirical coverage in a subset of patients.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Hockney SM, Steker D, Bhasin A, et al. Role of bone biopsy and deep tissue culture for antibiotic stewardship in diabetic foot osteomyelitis. J Antimicrob Chemother. 2022. PMID: 36214165. doi:10.1093/jac/dkac345

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。